Algert Global’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$281K	Buy	+21,920	New	+$279K	﹤0.01%	1033
2025 Q1	–	Sell	-69,354	Closed	-$809K	–	1287
2024 Q4	$809K	Buy	69,354 +8,312	+14%	+$130K	0.02%	828
2024 Q3	$1.25M	Sell	61,042 -7,330	-11%	-$169K	0.03%	705
2024 Q2	$1.53M	Buy	68,372 +51,572	+307%	+$1.23M	0.05%	553
2024 Q1	$462K	Buy	16,800 +2,100	+14%	+$58.3K	0.02%	783
2023 Q4	$448K	Buy	+14,700	New	+$422K	0.02%	854
2023 Q2	–	Sell	-23,610	Closed	-$880K	–	1201
2023 Q1	$880K	Buy	+23,610	New	+$926K	0.04%	679
2022 Q3	–	Sell	-14,653	Closed	-$758K	–	1274
2022 Q2	$758K	Buy	14,653 +10,970	+298%	+$557K	0.06%	590
2022 Q1	$268K	Sell	3,683 -2,745	-43%	-$233K	0.02%	975
2021 Q4	$760K	Sell	6,428 -790	-11%	-$99K	0.09%	366
2021 Q3	$968K	Buy	+7,218	New	+$1.09M	0.13%	240